1-7 of 7
David P. Carbone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural Mesothelioma

Ferdinando Cerciello, Meena Choi, Sara L. Sinicropi-Yao, Katie Lomeo, Joseph M. Amann, Emanuela Felley-Bosco, Rolf A. Stahel, Bruce W.S. Robinson, Jenette Creaney, Harvey I. Pass, Olga Vitek, David P. Carbone
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2020) 29 (10): 1973–1982.
https://doi.org/10.1158/1055-9965.EPI-20-0543
Published: 01 October 2020
View article titled, Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural Mesothelioma
Open the PDF for Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural Mesothelioma in another window
Includes: Supplementary data
Journal Articles

Abstract C135: Notch as an immunologic basis of cancer disparity

Anil Shanker, Pierre P Massion, David P Carbone, Mikhail M Dikov
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2020) 29 (6_Supplement_2): C135.
https://doi.org/10.1158/1538-7755.DISP19-C135
Published: 01 June 2020
View article titled, Abstract C135: Notch as an immunologic basis of cancer disparity
Journal Articles

Abstract B108: Combining Notch immunostimulation and bortezomib with adoptive immunotherapy in breast cancer

Anshu Malhotra, Samuel Troy Pellom, Jr., David P. Carbone, Mikhail M. Dikov, Anil Shanker
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2011) 20 (10_Supplement): B108.
https://doi.org/10.1158/1055-9965.DISP-11-B108
Published: 21 October 2014
View article titled, Abstract B108: Combining Notch immunostimulation and bortezomib with adoptive immunotherapy in breast cancer
Journal Articles

Abstract B93: Resuscitating cancer immunosurveillance by combining Notch 1 and death receptor-activating therapy.

Duafalia F. Dudimah, Roman V. Uzhachenko, Samuel T. Pellom, Jr., Asel K. Biktasova, Mikhail M. Dikov, David P. Carbone, Anil Shanker
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2012) 21 (10_Supplement): B93.
https://doi.org/10.1158/1055-9965.DISP12-B93
Published: 26 March 2014
View article titled, Abstract B93: Resuscitating cancer immunosurveillance by combining Notch 1 and death receptor-activating therapy.
Journal Articles

Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules

Chad V. Pecot, Ming Li, Xueqiong J. Zhang, Rama Rajanbabu, Ciara Calitri, Aaron Bungum, James R. Jett, Joe B. Putnam, Carol Callaway-Lane, Steve Deppen, Eric L. Grogan, David P. Carbone, John A. Worrell, Karel G.M. Moons, Yu Shyr, Pierre P. Massion
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2012) 21 (5): 786–792.
https://doi.org/10.1158/1055-9965.EPI-11-0932
Published: 06 May 2012
View article titled, Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules
Open the PDF for Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules in another window
Includes: Supplementary data
Journal Articles

Detection of Tumor Epidermal Growth Factor Receptor Pathway Dependence by Serum Mass Spectrometry in Cancer Patients

Christine H. Chung, Erin H. Seeley, Heinrich Roder, Julia Grigorieva, Maxim Tsypin, Joanna Roder, Barbara A. Burtness, Athanassios Argiris, Arlene A. Forastiere, Jill Gilbert, Barbara Murphy, Richard M. Caprioli, David P. Carbone, Ezra E.W. Cohen
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2010) 19 (2): 358–365.
https://doi.org/10.1158/1055-9965.EPI-09-0937
Published: 07 February 2010
View article titled, Detection of Tumor Epidermal Growth Factor Receptor Pathway Dependence by Serum Mass Spectrometry in Cancer Patients
Open the PDF for Detection of Tumor Epidermal Growth Factor Receptor Pathway Dependence by Serum Mass Spectrometry in Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Cytoplasmic Clusterin Expression Is Associated with Longer Survival in Patients with Resected Non–Small Cell Lung Cancer

Jeffrey M. Albert, Adriana Gonzalez, Pierre P. Massion, Heidi Chen, Sandra J. Olson, Yu Shyr, Roberto Diaz, Eric S. Lambright, Alan Sandler, David P. Carbone, Joe B. Putnam, Jr., David H. Johnson, Bo Lu
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2007) 16 (9): 1845–1851.
https://doi.org/10.1158/1055-9965.EPI-07-0146
Published: 12 September 2007
View article titled, Cytoplasmic Clusterin Expression Is Associated with Longer Survival in Patients with Resected Non–Small Cell Lung Cancer
Open the PDF for Cytoplasmic Clusterin Expression Is Associated with Longer Survival in Patients with Resected Non–Small Cell Lung Cancer in another window